Market Cap 592.57M
Revenue (ttm) 18.14M
Net Income (ttm) -72.85M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 649,900
Avg Vol 936,122
Day's Range N/A - N/A
Shares Out 188.72M
Stochastic %K 2%
Beta 1.98
Analysts Strong Sell
Price Target $4.50

Company Profile

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 1 and phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the poten...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 469 0914
Address:
701 Veterans Circle, Warminster, United States
Buqqets
Buqqets Feb. 23 at 7:05 PM
$ABUS My belief has always been that this would run up to the 12-15 range in silence.....and then FOMO......then the buyout takes place. Can't have 1000% gainers out there on the tickers......but can certainly have a couple weeks of steady rise, speculation, and an eventual BO.
0 · Reply
Abus_MoFo
Abus_MoFo Feb. 23 at 6:51 PM
$ABUS some research regarding LNP heterogeneity. Forming of LNP particles is a stochastic process, thus it must fall within Gaussian distribution. But Moderna's LNP distribution has long left tail. And that could not be a coincidence. Statistically imposible. You can refer to M.Mitchel's papers regarding SM-102 lipid distribution. He explains that in plain english. https://doi.org/10.1038/s41587-025-02855-x
1 · Reply
Blueviking
Blueviking Feb. 23 at 6:46 PM
$ABUS Wow! We are here🥳🥳🥳🥳🥳 Bought this stock 5 years ago. Its been a long haul, but very glad that i can say: «I am still here with a lot of shares, extremely bullish» Congrats to all longs that have patiently held. We all deserve a nice profit here!!!
0 · Reply
anon75634
anon75634 Feb. 23 at 6:30 PM
$ABUS 9 days. tick tock...
0 · Reply
Blueviking
Blueviking Feb. 23 at 6:20 PM
$ABUS One thing for sure! Moderna is worried😂😂😂 Settlement within 2 weeks🥳🥳🥳🎯
0 · Reply
BalancedStrategies
BalancedStrategies Feb. 23 at 5:37 PM
$ABUS clinical-stage biotech exposure
0 · Reply
renoH4
renoH4 Feb. 23 at 5:32 PM
$ABUS If a settlement is even hinted at, short sellers will immediately go long – this could be the reason for a sensational price increase. Even the most inexperienced short seller must realize that profits on the short side are severely limited, but on the long side they are virtually unlimited.
1 · Reply
renoH4
renoH4 Feb. 23 at 5:22 PM
$ABUS ..As soon as it becomes known that a settlement is being negotiated, the stock will explode. A 100-200% increase in a single day would be possible – then, depending on the conditions, it will go up to $20, maybe even more, because the probability that Pfizer will also pay has increased enormously – and Pfizer has 2.5 times the revenue of Moderna! $$$
0 · Reply
jim64
jim64 Feb. 23 at 4:27 PM
$ABUS The real company is the one that developed the science not the one that stoked it.
1 · Reply
renoH4
renoH4 Feb. 23 at 3:51 PM
$ABUS Esential for me is the fact that moderna tried two Times to destroy the patent and they lost two Times. This Shows that they are playing a dirty game.imo 80 : 20 that Arbutus will win and 70 : 30 that Moderna Talks about a settlement.
0 · Reply
Latest News on ABUS
Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025

Apr 23, 2025, 2:01 AM EDT - 10 months ago

Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025


Arbutus, Burford Capital, And Cadiz With Chris DeMuth Jr.

Jan 30, 2025, 3:40 PM EST - 1 year ago

Arbutus, Burford Capital, And Cadiz With Chris DeMuth Jr.

BUR CDZI


Arbutus Provides 2025 Corporate and Financial Update

Jan 13, 2025, 7:30 AM EST - 1 year ago

Arbutus Provides 2025 Corporate and Financial Update


Arbutus to Present at Jefferies London Healthcare Conference

Nov 14, 2024, 7:30 AM EST - 1 year ago

Arbutus to Present at Jefferies London Healthcare Conference


Arbutus to Participate in Two Upcoming Investor Conferences

Sep 3, 2024, 7:30 AM EDT - 1 year ago

Arbutus to Participate in Two Upcoming Investor Conferences


Arbutus Distributors Ltd. News Release

Jun 3, 2024, 9:50 AM EDT - 1 year ago

Arbutus Distributors Ltd. News Release


Arbutus to Present Imdusiran Data at EASL Congress 2024

May 22, 2024, 2:00 AM EDT - 1 year ago

Arbutus to Present Imdusiran Data at EASL Congress 2024


Buqqets
Buqqets Feb. 23 at 7:05 PM
$ABUS My belief has always been that this would run up to the 12-15 range in silence.....and then FOMO......then the buyout takes place. Can't have 1000% gainers out there on the tickers......but can certainly have a couple weeks of steady rise, speculation, and an eventual BO.
0 · Reply
Abus_MoFo
Abus_MoFo Feb. 23 at 6:51 PM
$ABUS some research regarding LNP heterogeneity. Forming of LNP particles is a stochastic process, thus it must fall within Gaussian distribution. But Moderna's LNP distribution has long left tail. And that could not be a coincidence. Statistically imposible. You can refer to M.Mitchel's papers regarding SM-102 lipid distribution. He explains that in plain english. https://doi.org/10.1038/s41587-025-02855-x
1 · Reply
Blueviking
Blueviking Feb. 23 at 6:46 PM
$ABUS Wow! We are here🥳🥳🥳🥳🥳 Bought this stock 5 years ago. Its been a long haul, but very glad that i can say: «I am still here with a lot of shares, extremely bullish» Congrats to all longs that have patiently held. We all deserve a nice profit here!!!
0 · Reply
anon75634
anon75634 Feb. 23 at 6:30 PM
$ABUS 9 days. tick tock...
0 · Reply
Blueviking
Blueviking Feb. 23 at 6:20 PM
$ABUS One thing for sure! Moderna is worried😂😂😂 Settlement within 2 weeks🥳🥳🥳🎯
0 · Reply
BalancedStrategies
BalancedStrategies Feb. 23 at 5:37 PM
$ABUS clinical-stage biotech exposure
0 · Reply
renoH4
renoH4 Feb. 23 at 5:32 PM
$ABUS If a settlement is even hinted at, short sellers will immediately go long – this could be the reason for a sensational price increase. Even the most inexperienced short seller must realize that profits on the short side are severely limited, but on the long side they are virtually unlimited.
1 · Reply
renoH4
renoH4 Feb. 23 at 5:22 PM
$ABUS ..As soon as it becomes known that a settlement is being negotiated, the stock will explode. A 100-200% increase in a single day would be possible – then, depending on the conditions, it will go up to $20, maybe even more, because the probability that Pfizer will also pay has increased enormously – and Pfizer has 2.5 times the revenue of Moderna! $$$
0 · Reply
jim64
jim64 Feb. 23 at 4:27 PM
$ABUS The real company is the one that developed the science not the one that stoked it.
1 · Reply
renoH4
renoH4 Feb. 23 at 3:51 PM
$ABUS Esential for me is the fact that moderna tried two Times to destroy the patent and they lost two Times. This Shows that they are playing a dirty game.imo 80 : 20 that Arbutus will win and 70 : 30 that Moderna Talks about a settlement.
0 · Reply
countingguy2006
countingguy2006 Feb. 23 at 3:48 PM
$ABUS Bottom line. In the case of ABUS/ROIV vs. MRNA; MRNA is a proven thief who tinkers with formula percentages and creates FUD and tries to screws little companies because they don't want to spend money for legitimate IP license fees from smaller companies. They (Moderna) are going to court in 14 days to use their defense lawyers, after a 4 year lawsuit against them, to try to use objections, motions and the like to influence the judge to control the evidence presented against them, and subsequentially try to persuade the jury to rule in their favor. Attorney Berl, ABUS/ROIV's lawyer, has quite a job to do in convincing the jury that the "one hit wonder" Moderna has taken advantage of ABUS in a David vs. Goliath scenario as he proves literal infringement. After 9 years of deals with Moderna, before they be came public about one year before covid-19, this case case has become personal in nature to me, not just for investment reasons. First time I have feeling about a legal matter.
1 · Reply
wintogether
wintogether Feb. 23 at 2:49 PM
$ABUS lol, a real company is running while an ambulance chaser is staying stagnant or losing value everyday.
3 · Reply
Nile1
Nile1 Feb. 23 at 2:47 PM
$ABUS wait wait is there is a glitch or something? What is this volume now ?
1 · Reply
permabull6
permabull6 Feb. 23 at 4:21 AM
$ABUS Saw the post below on a Moderna subreddit discussing why they believe Moderna is going to win the case. It's quite a long comment but I found this snippet interesting. Thoughts? if Moderna can mix component A at any amount X and component B at any amount Y, and the resulting microscale ratio ends up being something other than X/Y but still falls within Arbutus’s ratio range, then it suggests many people could arrive at that “recipe” without needing Arbutus’s patent, thus potentially disqualifying its patent. And as you emphasized, since LNPs are not static at the microscale, even if they look static in bulk, how is Arbutus going to prove microscale ratios using a universally accepted method? They would also need to show that the fractionated LNPs remain intact during analysis. This is very different from the Dow v. Nova case, where the material in question is static where there is no such complication." Link to rest of comment: https://www.reddit.com/r/ModernaStock/comments/1r8iog1/comment/o65bbfw/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button
1 · Reply
pooldude44646
pooldude44646 Feb. 23 at 3:09 AM
$ABUS Judge Wolson Judicial Service per AI search... Nomination: President Trump first nominated him in May 2018. After the nomination expired, he was renominated in January 2019 and confirmed by the Senate in a 65–33 vote on May 2, 2019. Notable Procedures: Judge Wolson is known for implementing specific courtroom policies, such as a unique summary judgment procedure that requires parties to file a single, consolidated statement of facts. Recent Activity: In late 2025, he presided over a high-profile discrimination trial involving Drexel University.
0 · Reply
TaxEagle1040
TaxEagle1040 Feb. 23 at 2:46 AM
$ABUS Writing is on the wall for MRNA!!!! GO ABUS!!! Very, very, bullish!!!
0 · Reply
TaxEagle1040
TaxEagle1040 Feb. 23 at 2:44 AM
$ABUS MRNA finally coming clean as reality is settling in that they are about lose big time in court!!!! ABUS get ready for billions of dollars and hopefully treble (3x) damages.
0 · Reply
hman62
hman62 Feb. 23 at 1:42 AM
$ABUS Keep reading that the Jury will not be able to follow the Science. Maybe, UNTIL they hear the words COVID and Moderna. Every person in the WORLD was affected by COVID. For/Against Shot. Got/Did't get COVID. Jobs. Death. Illness "blamed" on Shot, etc. EVERYONE has memories and stories. SO when they hear COVID, they will become VERY engaged. And WHO do you think an engaged Jury favors? Berl and ABUS. He is a master and will explain so they understand and he will lay it all out. And he will explain that ABUS is JUST the delivery system. Nothing to do with what is in the magic bubble/box (LNP). Can't be upset with ABUS. Metaphor. You order a pizza from Papas Johns (MRNA) and GrubHub delivers(LNP). The Pizza has the wrong toppings. Can't blame Delivery guy (LNP). Eat pizza and get sick. Not delivery guys fault. But then you observe and ask yourself did Papa Johns use/copy/steal Dominoes pizza box design (ABUS/LNP) for the DELIVERY? Bad COVID memories fall on MRNA not ABUS.
1 · Reply
jim64
jim64 Feb. 23 at 12:33 AM
$ABUS Things are heating up…
0 · Reply
hman62
hman62 Feb. 22 at 11:40 PM
$ABUS Just a heads up. Having been here a while and done some posting, I have a personal barometer that I use to gauge retail new interest. In the past when there is a run up to an upcoming catalysts, I watch and look for ALL the NEW posters and the new posters that respond to my posts. We all know the regulars here, BUT pay attention. And be patient. They will ask all the questions we have asked and answered the last 5 years. But it tells you that NEW eyes and investors are jumping on the aBUS. And I have to wonder about the 13.5M shares shorted and a tight Float 150M (88% owned by Tutes/Funds 131.73M) Only 17.7 M shares Retail/Other left to cover. And I am not selling mine, you? So it could get really interesting FAST!! FOMO. Good Luck Shake and Bake
2 · Reply
BrenFal0919
BrenFal0919 Feb. 22 at 10:40 PM
$ABUS i sure hope all the $MRNA investors have read the fine print!
1 · Reply
postup1
postup1 Feb. 22 at 10:07 PM
$ABUS Moderna Form 10-K, filed Feb. 20th, 2026 Part 3 “Defense of infringement and other claims, regardless of their merit, involves substantial litigation expense and diverts employee resources from our business. In the event of a successful infringement claim against us, we may have to pay substantial damages, including treble damages and attorneys’ fees for willful infringement, pay royalties, redesign our infringing products or obtain one or more licenses from third parties, which may not be made available on commercially favorable terms, if at all, or may require substantial time and expense.” P. 58 - 59
3 · Reply